Miaoqin Wu

SSGJ-601 versus Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion: 52-Week Results from a Phase 3 Study

Linni Wang, Zhiqing Li, Xinjun Ren, Liangzhang Tan et autres

cn (code pays fourni par la source)

Effect of Key Baseline Disease Characteristics on Aflibercept 8 mg Dosing Interval Extension

Justus G. Garweg, Varun Chaudhary, Xin Zhang, Sérgio Leal et autres

OBJECTIVE: Post hoc analysis of the PULSAR phase 3 trial (NCT04423718) to determine whether dosing interval outcomes were associated with key baseline disease characteristics. DESIGN: Exploratory post hoc analysis of PULSAR, a 96-week, double-masked, active-controlled, randomized clinical trial in patients with treatment-naïve …

ch, ca, de, es, it, ar, au, us, at, bg, br, cn, sk, cz, ee, fr, ge, hu, il (code pays fourni par la source)